Effective June 17, 2019 - HOPE Act Co-prescribing Guidelines for Overdose Reversal Drugs (Naloxone)The purpose of these regulations is to provide guidance
to healthcare practitioners, who are prescribing opioids to treat a patient's pain
or an opioid use disorder, in determining the appropriate circumstances in which
to consider prescribing an opioid overdose reversal drug. These guidelines are being
promulgated in accordance with H.B. 1329/S.B. 967 Heroin and Opioid Prevention Effort
(HOPE) and Treatment Act of 2017 (Chs. 571 and 572, Acts of 2017).
Interstate Medical Licensure Compact (IMLC) legislation passed during 2018 Session. Implementation slated for July 1, 2019. Click for Press Release from IMLC
Effective April 23, 2018 - Regulations under COMAR 10.32.07 regarding unlicensed medical practitioners (UMPs) are repealed. There is no requirement for UMPs to register with the Board.
Effective March 26, 2018:
Primary supervising physicians of physician assistants do not need to file with the Board documentation about alternate supervising physicians (in any practice setting). See COMAR 10.32.03.07A(3)(d). Primary supervising physicians must ensure that alternate supervising physician documentation is readily available, accessible, and provided to the Board upon request.